These data indicate that SGT-53 can convert otherwise unresponsive mouse NSCLC tumors into anti-PD-1-responsive tumors resulting in reduced tumor growth and increased tumor cell apoptosis. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.